222 related articles for article (PubMed ID: 15702703)
41. Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
Passemard M; Koehrer P; Juniot A; Bron AM; Creuzot-Garcher C
Retina; 2012 Oct; 32(9):1868-73. PubMed ID: 22495328
[TBL] [Abstract][Full Text] [Related]
42. [Anticoagulation in surgery, after hemorrhagic complications and in pregnancy].
Gohlke-Bärwolf C
Z Kardiol; 1998; 87 Suppl 4():56-62. PubMed ID: 9857468
[TBL] [Abstract][Full Text] [Related]
43. [Warfarin combined with blood platelet inhibition].
Vik-Mo H
Tidsskr Nor Laegeforen; 2011 Feb; 131(3):252-3. PubMed ID: 21304575
[TBL] [Abstract][Full Text] [Related]
44. [Management of antithrombotic therapy in patients undergoing implantation or replacement of cardiac implantable electronic devices].
Zacà V; Marcucci R; Parodi G; Limbruno U; Notarstefano P; Pieragnoli P; Di Cori A; Bongiorni MG; Casolo G
G Ital Cardiol (Rome); 2014 Jan; 15(1):56-72. PubMed ID: 24503736
[TBL] [Abstract][Full Text] [Related]
45. [Anticoagulation and antiaggregation during pregnancy].
Biasiutti FD; Strebel JK
Ther Umsch; 2003 Jan; 60(1):54-8. PubMed ID: 12638480
[TBL] [Abstract][Full Text] [Related]
46. Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication?
Eng M; Brock G; Li X; Chen Y; Ravindra KV; Buell JF; Marvin MR
Clin Transplant; 2011; 25(2):292-6. PubMed ID: 20529097
[TBL] [Abstract][Full Text] [Related]
47. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
Levi MM; Eerenberg E; Löwenberg E; Kamphuisen PW
Neth J Med; 2010 Feb; 68(2):68-76. PubMed ID: 20167958
[TBL] [Abstract][Full Text] [Related]
48. Preoperative management of anticoagulation and antiplatelet agents.
Gleason LJ; Friedman SM
Clin Geriatr Med; 2014 May; 30(2):219-27. PubMed ID: 24721362
[TBL] [Abstract][Full Text] [Related]
49. Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options.
Rothman MT
Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):465-74. PubMed ID: 16265587
[TBL] [Abstract][Full Text] [Related]
50. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
Ganetsky VS; Hadley DE; Thomas TF
Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
[TBL] [Abstract][Full Text] [Related]
51. Antithrombotic strategies in patients on oral anticoagulant therapy undergoing percutaneous coronary intervention: a proposed algorithm based on individual risk stratification.
Patti G; Di Sciascio G
Catheter Cardiovasc Interv; 2010 Jan; 75(1):128-34. PubMed ID: 19670304
[TBL] [Abstract][Full Text] [Related]
52. Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?
Marín F; Bonacasa B; Valdés M
Thromb Haemost; 2010 Jan; 103(1):11-2. PubMed ID: 20062940
[No Abstract] [Full Text] [Related]
53. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
Guo Y; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
[TBL] [Abstract][Full Text] [Related]
54. Management of the antiplatelet therapy during the diagnosis of venous thromboembolism disease: A national survey of French general practitioners' compared to the French vascular physicians' management.
Fayol A; Plaisance L; Poenou G; Helfer H; Le Jeune S; Mahé I
J Med Vasc; 2020 May; 45(3):107-113. PubMed ID: 32402424
[TBL] [Abstract][Full Text] [Related]
55. [What anticoagulant therapy should be used for what form of atrial fibrillation?].
Frantz E
Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997
[No Abstract] [Full Text] [Related]
56. [Prevention of embolisms in atrial fibrillation: anticoagulation and antiplatelet therapy].
Kienast J
Z Kardiol; 1994; 83 Suppl 5():49-58. PubMed ID: 7846945
[TBL] [Abstract][Full Text] [Related]
57. Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system.
Attisani M; Centofanti P; La Torre M; Campanella A; Sansone F; Rinaldi M
J Artif Organs; 2010 Dec; 13(4):202-6. PubMed ID: 21127929
[TBL] [Abstract][Full Text] [Related]
58. The Periprocedural Management of Anticoagulation and Platelet Aggregation Inhibitors in Endoscopic Interventions.
Lange CM; Fichtlscherer S; Miesbach W; Zeuzem S; Albert J
Dtsch Arztebl Int; 2016 Feb; 113(8):129-35. PubMed ID: 26976713
[TBL] [Abstract][Full Text] [Related]
59. An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves.
Bussey HI
J Heart Valve Dis; 2004 May; 13(3):319-24. PubMed ID: 15222274
[TBL] [Abstract][Full Text] [Related]
60. New anticoagulants, reversal agents, and clinical considerations for perioperative practice.
Hart BM; Ferrell SM; Motejunas MW; Bonneval LA; Cornett EM; Urman RD; Kaye AD
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):165-178. PubMed ID: 30322457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
